GKOS - Sight Sciences slumps amid risk for Medicare coverage for glaucoma procedure
2023-10-26 14:33:14 ET
More on Glaukos, Sight Sciences, etc.
- Glaukos: Continued Growth Rates, Regulatory Tailwinds, And Support
- Sight Sciences: Staying Bullish After Q2 Results Beat
- Sight Sciences, Inc. (SGHT) Q2 2023 Earnings Call Transcript
- Piper Sandler cuts Sight Sciences to neutral, cites lowered guidance
- Biggest stock movers today: Rocket Lab USA, Riot Platforms, WestRock, Oracle and more
For further details see:
Sight Sciences slumps amid risk for Medicare coverage for glaucoma procedure